Switch to:
More From Other Websites
New Data Shows Greater In Vitro Potency for VIBATIV(R) (Telavancin) Against Multidrug-Resistant... Apr 24 2015
Nasdaq stocks posting largest percentage decreases Apr 24 2015
Theravance Biopharma to Present New Data Highlighting in vitro Potency of VIBATIV(R) (telavancin)... Apr 16 2015
THERAVANCE INC Files SEC form 8-K, Other Events Apr 16 2015
Theravance Biopharma to Present at the Needham Healthcare Conference Apr 07 2015
Theravance Biopharma Announces New Employment Inducement Awards Apr 02 2015
Pharmacyclics Begins Imbruvica Combination Cancer Study - Analyst Blog Apr 02 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Mar 31 2015
Should Theravance (THRX) Be On Your Radar Now? - Tale of the Tape Mar 24 2015
KB Home and Biogen are big market movers Mar 20 2015
Theravance/Glaxo's Breo Ellipta Gets Mixed FDA Panel View - Analyst Blog Mar 20 2015
THERAVANCE INC Files SEC form 8-K, Other Events Mar 20 2015
FDA panel backs Glaxo inhaler for adults, not adolescents Mar 19 2015
GSK and Theravance announce outcome of US FDA Advisory Committee on BREO® ELLIPTA® in asthma Mar 19 2015
GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthma Mar 19 2015
FDA panel backs Glaxo asthma drug for adults, not adolescents Mar 19 2015
Theravance Announces Trading in Common Stock Halted Mar 19 2015
Pharmacyclics' Imbruvica Encourages in a Phase III Study - Analyst Blog Mar 17 2015
THERAVANCE INC Files SEC form 8-K, Regulation FD Disclosure Mar 17 2015
FDA staff finds no new safety problems with Glaxo's asthma drug Mar 17 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK